IL150235A0 - Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect - Google Patents
Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effectInfo
- Publication number
- IL150235A0 IL150235A0 IL15023500A IL15023500A IL150235A0 IL 150235 A0 IL150235 A0 IL 150235A0 IL 15023500 A IL15023500 A IL 15023500A IL 15023500 A IL15023500 A IL 15023500A IL 150235 A0 IL150235 A0 IL 150235A0
- Authority
- IL
- Israel
- Prior art keywords
- indol
- benzyl
- substituted
- acid derivatives
- glyoxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19962300A DE19962300A1 (de) | 1999-12-23 | 1999-12-23 | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
PCT/EP2000/012947 WO2001047913A2 (de) | 1999-12-23 | 2000-12-19 | Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150235A0 true IL150235A0 (en) | 2002-12-01 |
Family
ID=7934006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15023500A IL150235A0 (en) | 1999-12-23 | 2000-12-19 | Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
Country Status (31)
Country | Link |
---|---|
US (1) | US6432987B2 (ko) |
EP (1) | EP1240157B1 (ko) |
JP (1) | JP2003519137A (ko) |
KR (1) | KR100747425B1 (ko) |
CN (1) | CN1283637C (ko) |
AR (1) | AR027098A1 (ko) |
AT (1) | ATE259364T1 (ko) |
AU (1) | AU772745B2 (ko) |
BG (1) | BG106924A (ko) |
BR (1) | BR0016712A (ko) |
CA (1) | CA2395259A1 (ko) |
CO (1) | CO5251472A1 (ko) |
CZ (1) | CZ20022094A3 (ko) |
DE (2) | DE19962300A1 (ko) |
DK (1) | DK1240157T3 (ko) |
ES (1) | ES2215768T3 (ko) |
HK (1) | HK1054038B (ko) |
HU (1) | HUP0203716A3 (ko) |
IL (1) | IL150235A0 (ko) |
MX (1) | MXPA02006229A (ko) |
NO (1) | NO324750B1 (ko) |
NZ (2) | NZ519977A (ko) |
PL (1) | PL195014B1 (ko) |
PT (1) | PT1240157E (ko) |
RU (1) | RU2266280C2 (ko) |
SK (1) | SK8752002A3 (ko) |
TR (1) | TR200400601T4 (ko) |
TW (1) | TWI284128B (ko) |
UA (1) | UA75060C2 (ko) |
WO (1) | WO2001047913A2 (ko) |
ZA (1) | ZA200204896B (ko) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19946301A1 (de) * | 1998-04-02 | 2001-04-19 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften |
DE19814838C2 (de) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
DE10037310A1 (de) * | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
DE10318611A1 (de) * | 2003-04-24 | 2004-11-11 | Elbion Ag | 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika |
DE10318609A1 (de) * | 2003-04-24 | 2004-11-11 | Elbion Ag | 5-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika |
JP4878285B2 (ja) * | 2003-06-05 | 2012-02-15 | エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング | アポトーシス誘発作用を有するインドール誘導体 |
US7211588B2 (en) * | 2003-07-25 | 2007-05-01 | Zentaris Gmbh | N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation |
US7749999B2 (en) | 2003-09-11 | 2010-07-06 | Itherx Pharmaceuticals, Inc. | Alpha-ketoamides and derivatives thereof |
US7268159B2 (en) * | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
DE102004031538A1 (de) * | 2004-06-29 | 2006-02-09 | Baxter International Inc., Deerfield | Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit |
US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
CN101443006B (zh) | 2004-12-31 | 2012-10-10 | 雷迪美国治疗股份有限公司 | 作为cetp抑制剂的新颖的苄胺衍生物 |
EP2363128B1 (en) * | 2005-03-11 | 2016-02-17 | Vertex Pharmaceuticals Incorporated | Indole modulators of ATP-binding cassette transporters |
SG176477A1 (en) * | 2006-08-07 | 2011-12-29 | Ironwood Pharmaceuticals Inc | Indole compounds |
EP2091532A1 (en) * | 2006-11-28 | 2009-08-26 | Ziopharm Oncology, Inc. | Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer |
CN106822080A (zh) | 2009-04-29 | 2017-06-13 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
AR084433A1 (es) | 2010-12-22 | 2013-05-15 | Ironwood Pharmaceuticals Inc | Inhibidores de la faah y composiciones farmaceuticas que los contienen |
JP5964965B2 (ja) | 2011-08-18 | 2016-08-03 | ドクター レディズ ラボラトリーズ リミテッド | コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物 |
KR101803866B1 (ko) | 2011-09-27 | 2017-12-04 | 닥터 레디스 레보러터리즈 리미티드 | 동맥경화증 치료에 유용한 콜레스테릴 에스테르-전달 단백질(cetp) 억제제로서 5-벤질아미노메틸-6-아미노피라졸로[3,4-b]피리딘 유도체 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950701317A (ko) * | 1992-05-08 | 1995-03-23 | 오오쓰까 아끼히꼬 | 인돌 유도체(Indole Derivative) |
IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
WO1995022524A1 (en) * | 1994-02-22 | 1995-08-24 | Merrell Pharmaceuticals Inc. | Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
UA47387C2 (uk) * | 1994-04-01 | 2002-07-15 | Елі Ліллі Енд Компані | 1H-ІНДОЛ-3-ГЛІОКСИЛАМІДИ ЯК ІНГІБІТОРИ sPLA<sub>2</sub> ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ |
DE19636150A1 (de) * | 1996-09-06 | 1998-03-12 | Asta Medica Ag | N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung |
EP0987250A4 (en) * | 1997-02-20 | 2000-12-06 | Shionogi & Co | INDOLDICARBONIC ACID DERIVATIVES |
US5972988A (en) * | 1997-03-26 | 1999-10-26 | Eli Lilly And Company | Method for treatment of chronic bronchitis using indole compounds |
WO1998047507A1 (en) * | 1997-04-24 | 1998-10-29 | Shionogi & Co., Ltd. | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
TW455581B (en) * | 1997-06-26 | 2001-09-21 | Lilly Co Eli | Process for preparing 4-substituted-1H-indole-3-glyoxamides |
WO1999009978A1 (en) * | 1997-08-28 | 1999-03-04 | Eli Lilly And Company | Method for treatment of non-rheumatoid athritis |
CA2304482A1 (en) * | 1997-09-26 | 1999-04-08 | Eli Lilly And Company | Method for the treatment of cystic fibrosis |
ES2241178T3 (es) * | 1997-10-27 | 2005-10-16 | Eli Lilly And Company | Profarmacos de ester de morlino-n-etilo de inhibidores indolicos de spla 2. |
CA2309135A1 (en) * | 1997-10-27 | 1999-05-06 | Michael Lyle Denney | N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
WO1999021545A1 (en) * | 1997-10-27 | 1999-05-06 | Eli Lilly And Company | ISOPROPYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
WO1999024033A1 (en) * | 1997-11-12 | 1999-05-20 | Shionogi & Co., Ltd. | Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
JP2001522883A (ja) * | 1997-11-14 | 2001-11-20 | イーライ・リリー・アンド・カンパニー | アルツハイマー病の処置 |
CA2322162A1 (en) * | 1998-02-25 | 1999-09-02 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
DE19814838C2 (de) | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
DZ2770A1 (fr) * | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. |
TR200003130T2 (tr) * | 1998-04-28 | 2001-01-22 | Arzneimittelwerk Dresden Gmbh | Yeni hidroksiindoller, bunların fosfodiesteraz 4 inhibitörleri olarak kullanımları ve hazırlanmaları için işlemler |
DE19818964A1 (de) * | 1998-04-28 | 1999-11-04 | Dresden Arzneimittel | Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung |
SK16342000A3 (sk) * | 1998-05-01 | 2002-04-04 | Eli Lilly And Company | Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy |
ES2230847T3 (es) * | 1998-05-01 | 2005-05-01 | Eli Lilly And Company | Esteres inhibidores de spla2. |
WO2000067802A1 (en) * | 1999-05-10 | 2000-11-16 | Protarga, Inc. | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof |
TWI269654B (en) * | 1999-09-28 | 2007-01-01 | Baxter Healthcare Sa | N-substituted indole-3-glyoxylamide compounds having anti-tumor action |
-
1999
- 1999-12-23 DE DE19962300A patent/DE19962300A1/de not_active Withdrawn
-
2000
- 2000-12-15 US US09/736,431 patent/US6432987B2/en not_active Expired - Fee Related
- 2000-12-19 PT PT00983349T patent/PT1240157E/pt unknown
- 2000-12-19 JP JP2001549383A patent/JP2003519137A/ja not_active Withdrawn
- 2000-12-19 ES ES00983349T patent/ES2215768T3/es not_active Expired - Lifetime
- 2000-12-19 TR TR2004/00601T patent/TR200400601T4/xx unknown
- 2000-12-19 SK SK875-2002A patent/SK8752002A3/sk unknown
- 2000-12-19 RU RU2002120462/04A patent/RU2266280C2/ru not_active IP Right Cessation
- 2000-12-19 NZ NZ519977A patent/NZ519977A/en unknown
- 2000-12-19 NZ NZ533731A patent/NZ533731A/en unknown
- 2000-12-19 IL IL15023500A patent/IL150235A0/xx not_active IP Right Cessation
- 2000-12-19 HU HU0203716A patent/HUP0203716A3/hu unknown
- 2000-12-19 MX MXPA02006229A patent/MXPA02006229A/es active IP Right Grant
- 2000-12-19 CZ CZ20022094A patent/CZ20022094A3/cs unknown
- 2000-12-19 EP EP00983349A patent/EP1240157B1/de not_active Expired - Lifetime
- 2000-12-19 AT AT00983349T patent/ATE259364T1/de not_active IP Right Cessation
- 2000-12-19 DE DE50005284T patent/DE50005284D1/de not_active Expired - Fee Related
- 2000-12-19 BR BR0016712-6A patent/BR0016712A/pt not_active Application Discontinuation
- 2000-12-19 UA UA2002076107A patent/UA75060C2/uk unknown
- 2000-12-19 PL PL355684A patent/PL195014B1/pl unknown
- 2000-12-19 WO PCT/EP2000/012947 patent/WO2001047913A2/de active IP Right Grant
- 2000-12-19 AU AU20119/01A patent/AU772745B2/en not_active Ceased
- 2000-12-19 KR KR1020027007933A patent/KR100747425B1/ko not_active IP Right Cessation
- 2000-12-19 TW TW089127265A patent/TWI284128B/zh not_active IP Right Cessation
- 2000-12-19 CA CA002395259A patent/CA2395259A1/en not_active Abandoned
- 2000-12-19 CN CNB008182094A patent/CN1283637C/zh not_active Expired - Fee Related
- 2000-12-19 DK DK00983349T patent/DK1240157T3/da active
- 2000-12-22 AR ARP000106916A patent/AR027098A1/es not_active Application Discontinuation
- 2000-12-22 CO CO00097375A patent/CO5251472A1/es not_active Application Discontinuation
-
2002
- 2002-06-19 ZA ZA200204896A patent/ZA200204896B/en unknown
- 2002-06-21 NO NO20023039A patent/NO324750B1/no unknown
- 2002-07-16 BG BG106924A patent/BG106924A/bg unknown
-
2003
- 2003-09-09 HK HK03106408.0A patent/HK1054038B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150235A0 (en) | Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect | |
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
IL139470A0 (en) | Oxyiminoalkanoic acid derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
PL345794A1 (en) | Aminomethylcarboxylic acid derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
IL148058A0 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives | |
HK1044940A1 (zh) | 異噁唑咪唑羧酰胺衍生物 | |
IL147216A0 (en) | Arylsulfonamido-substituted hydroxamic acid derivatives | |
HK1034969A1 (en) | Dihydroxyhexanoic acid derivatives. | |
HK1047274A1 (zh) | 氨基苯甲酸衍生物 | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
GB9912905D0 (en) | An animal over-garment | |
GB9929979D0 (en) | Hydroxamic acid derivatives | |
HK1047085A1 (zh) | 二酰基肼衍生物 | |
GB9925880D0 (en) | B-Carboline derivatives | |
HK1048638A1 (zh) | Cyclopenteneone衍生物 | |
HK1045987A1 (zh) | 3-氨基-2-苄基-1-苯基-丙烷衍生物 | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
SI1240157T1 (en) | Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect | |
GB0125901D0 (en) | Compositions stabilized dioxopiperazinyl derivatives | |
GB0017435D0 (en) | 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivatives | |
GB9907134D0 (en) | Antimor napthylcombretastatin derivatives | |
HK1043987A1 (zh) | 硫-羥吲衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |